J&J's Janssen Hit With $70 Mln Verdict in Risperdal TrialJ&J's Janssen Hit With $70 Mln Verdict in Risperdal Trial

A U.S. jury has awarded $70 million to the family of a boy who developed breasts after taking Johnson & Johnson unit Janssen Pharmaceuticals' antipsychotic drug Risperdal (risperidone). Reuters Health Information
Source: Medscape Today Headlines - Category: Consumer Health News Tags: Psychiatry News Source Type: news